Alkem Laboratories Overview
- Year Founded
-
1973
- Status
-
Public
- Employees
-
21,057
- Stock Symbol
-
ALKEM
- Investments
-
15
- Share Price
-
$57.85
- (As of Thursday Closing)
Alkem Laboratories General Information
Description
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.
Contact Information
Website
www.alkemlabs.comCorporate Office
- Alkem House, Senapati Bapat Marg
- Lower Parel
- Mumbai, 400013
- India
Corporate Office
- Alkem House, Senapati Bapat Marg
- Lower Parel
- Mumbai, 400013
- India
Alkem Laboratories Stock Performance
As of 17-Apr-2025, Alkem Laboratories’s stock price is $57.85. Its current market cap is $6.92B with 120M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $57.85 | $57.83 | $51.43 - $76.72 | $6.92B | 120M | 141K | $2.15 |
Alkem Laboratories Financials Summary
As of 31-Dec-2024, Alkem Laboratories has a trailing 12-month revenue of $1.5B.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
|---|---|---|---|---|
| EV | 7,512,420 | 6,844,011 | 4,846,691 | 5,593,124 |
| Revenue | 1,497,225 | 1,502,580 | 1,424,739 | 1,410,868 |
| EBITDA | 317,150 | 258,785 | 191,512 | 277,341 |
| Net Income | 257,322 | 216,918 | 122,565 | 220,866 |
| Total Assets | 1,867,640 | 1,675,576 | 1,855,401 | |
| Total Debt | 0 | 170,086 | 170,117 | 351,873 |
Alkem Laboratories Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Alkem Laboratories Comparisons
Industry
Financing
Details
Alkem Laboratories Competitors (65)
One of Alkem Laboratories’s 65 competitors is Torrent Pharmaceuticals, a Corporation company based in Ahmedabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Corporation | Ahmedabad, India | ||||
| Cipla | Corporation | Mumbai, India | ||||
| Mankind Pharma | Formerly PE-Backed | New Delhi, India | ||||
| Marksans Pharma | Corporation | Mumbai, India | ||||
| Ajanta Pharma | Corporation | Mumbai, India |
Alkem Laboratories Patents
Alkem Laboratories Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240374527-A1 | Pharmaceutical composition comprising lumateperone | Pending | 08-May-2023 | ||
| US-D1063062-S1 | Nasal spray device | Active | 10-Mar-2022 | ||
| US-20230240985-A1 | Stable pharmaceutical composition of topiramate | Inactive | 28-Jan-2022 | ||
| US-20230210830-A1 | Stable pharmaceutical composition of nimodipine | Inactive | 01-Jan-2022 | ||
| CA-3213156-A1 | Nasal compositions comprising alcaftadine | Pending | 01-Apr-2021 | A61K9/0043 |
Alkem Laboratories Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Alkem Laboratories Investments & Acquisitions (15)
Alkem Laboratories’s most recent deal was a Merger/Acquisition with Bombay Ortho Industries for . The deal was made on 07-Feb-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Bombay Ortho Industries | 07-Feb-2025 | Merger/Acquisition | Other Devices and Supplies | ||
| Sahajanand Medical Technologies | 15-Oct-2024 | Merger/Acquisition | Surgical Devices | ||
| Novartis India | 26-Sep-2024 | Merger/Acquisition | Pharmaceuticals | ||
| Zapkey | 05-May-2023 | Early Stage VC | Real Estate Services (B2C) | ||
| Enzene | 29-Jan-2023 | Later Stage VC | Biotechnology |
Alkem Laboratories ESG
Risk Overview
Risk Rating
Updated January, 18, 2025
29.26 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,109
Rank
Percentile
Pharmaceuticals
Industry
of 861
Rank
Percentile
Pharmaceuticals
Subindustry
of 430
Rank
Percentile
Alkem Laboratories Exits (1)
Alkem Laboratories’s most recent exit was on 28-Aug-2017 from Medlife. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Medlife | 28-Aug-2017 | Completed |
|
Alkem Laboratories Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| S&b Pharma | Azusa, CA | 2012 | |
| Pharmacor | Sydney, Australia | 2007 | |
| Ascend Laboratories | Parsippany, NJ | 2000 |
Alkem Laboratories FAQs
-
When was Alkem Laboratories founded?
Alkem Laboratories was founded in 1973.
-
Where is Alkem Laboratories headquartered?
Alkem Laboratories is headquartered in Mumbai, India.
-
What is the size of Alkem Laboratories?
Alkem Laboratories has 21,057 total employees.
-
What industry is Alkem Laboratories in?
Alkem Laboratories’s primary industry is Pharmaceuticals.
-
Is Alkem Laboratories a private or public company?
Alkem Laboratories is a Public company.
-
What is Alkem Laboratories’s stock symbol?
The ticker symbol for Alkem Laboratories is ALKEM.
-
What is the current stock price of Alkem Laboratories?
As of 17-Apr-2025 the stock price of Alkem Laboratories is $57.85.
-
What is the current market cap of Alkem Laboratories?
The current market capitalization of Alkem Laboratories is $6.92B.
-
What is Alkem Laboratories’s current revenue?
The trailing twelve month revenue for Alkem Laboratories is $1.5B.
-
Who are Alkem Laboratories’s competitors?
Torrent Pharmaceuticals, Cipla, Mankind Pharma, Marksans Pharma, and Ajanta Pharma are some of the 65 competitors of Alkem Laboratories.
-
What is Alkem Laboratories’s annual earnings per share (EPS)?
Alkem Laboratories’s EPS for 12 months was $2.15.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
